









Markets
/
Stocks
/
nasdaq-crdl
/

Cardiol Therapeutics Inc

CRDL

View Detailed Chart

1.380USD

-0.110-7.38%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

114.00MMarket Cap

LossP/E TTM



Cardiol Therapeutics Inc

1.380

-0.110-7.38%

Overview Company Financials

Financials

Intraday

30m

Today

-7.38%

5 Days

-4.17%

1 Month

-10.39%

6 Months

+3.76%

Year to Date

+7.81%

1 Year

-31.34%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

BUY

Current Rating

8.500

Target Price

515.94%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Cardiol Therapeutics Inc

CRDL

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(3)

Buy(5)

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.018

Buy

RSI(14)

49.985

Neutral

STOCH(KDJ)(9,3,3)

59.316

Sell

ATR(14)

0.107

High Vlolatility

CCI(14)

31.935

Neutral

Williams %R

46.667

Neutral

TRIX(12,20)

0.257

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

1.468

Sell

MA10

1.424

Sell

MA20

1.372

Buy

MA50

1.350

Buy

MA100

1.202

Buy

MA200

1.341

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

Ticker SymbolCRDL

CompanyCardiol Therapeutics Inc

CEOMr. David Elsley

Websitehttps://www.cardiolrx.com/